Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
18.94 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 381.393 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 381.393 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
| Net Receivables
| 1.637 | 0 | 0 | 0.082 | 0 | 0 |
| Inventory
| 1.208 | 0 | 0 | -0.082 | 0 | 0 |
| Other Current Assets
| 13.194 | 5.127 | 3.267 | 3.872 | 11.836 | 0.023 |
| Total Current Assets
| 397.432 | 160.512 | 186.526 | 291.368 | 255.601 | 0.902 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 3.621 | 3.494 | 2.564 | 3.359 | 1.396 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 2.863 | 0.505 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 9.926 | 0.299 | 0.341 | 0.384 | 0.181 | 0 |
| Total Non-Current Assets
| 16.41 | 4.298 | 2.905 | 3.743 | 1.577 | 0 |
| Total Assets
| 413.842 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 12.601 | 9.997 | 5.15 | 16.782 | 0.699 | 0.055 |
| Short Term Debt
| 0.726 | 0.708 | 0.487 | 7.827 | 0.161 | 1.95 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 18.343 | 0 | 0 | 0 | 2.475 | -1.95 |
| Other Current Liabilities
| 7.111 | 15.532 | 13.284 | 30.915 | 0.413 | 2.133 |
| Total Current Liabilities
| 38.781 | 26.237 | 18.921 | 55.524 | 3.748 | 2.188 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 138.304 | 96.362 | 90.854 | 41.191 | 23.412 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 309.516 | 117.025 | 7.5 | 4.125 | 2.063 | 0 |
| Total Non-Current Liabilities
| 447.82 | 213.387 | 98.354 | 45.316 | 25.475 | 0 |
| Total Liabilities
| 486.601 | 239.624 | 117.275 | 100.84 | 29.223 | 2.188 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.005 | 0.003 | 0.003 | 0.003 | 0.002 | 0 |
| Retained Earnings
| -928.685 | -727.093 | -529.37 | -385.487 | -256.419 | -1.288 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 855.921 | 652.276 | 601.523 | 579.755 | 484.372 | 0.002 |
| Total Shareholders Equity
| -72.759 | -74.814 | 72.156 | 194.271 | 227.955 | -1.286 |
| Total Equity
| -72.759 | -74.814 | 72.156 | 194.271 | 227.955 | -1.286 |
| Total Liabilities & Shareholders Equity
| 413.842 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |